About this trial
This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.
Eligibility criteria
Qualifiers
Patients aged 55-74 years diagnosed with non-communicable diseases.
Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
Able to communicate, read, and write in Thai.
Disqualifiers
Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
Having severe cognitive impairment or psychiatric disorders that prevent participation.
Having severe complications or being in an unstable clinical condition.
Planning to move out of the study area during the 12-week study period.
Trial design
Treatments tested in this trial
- Health Literacy Promotion Program (HLP-CKD)